What Keeps Drug Companies Alive? Three Decades of Evidence Distilled
A systematic review of 58 studies published between 1995 and 2024 identifies 63 factors influencing pharmaceutical company survival, finding that ...
A systematic review of 58 studies published between 1995 and 2024 identifies 63 factors influencing pharmaceutical company survival, finding that ...
An interrupted time-series analysis of nearly 10,000 medicine presentations shows that Argentina's December 2023 economic shock left minimum-pension retirees facing ...
A Lancet modelling study finds US Medicare's Most-Favoured-Nation drug pricing policy could save billions but may push manufacturers to raise ...
A landmark 27-country analysis finds that demand-side policies, especially gain-sharing models and switching programmes, are the strongest levers for boosting ...
The first unified analysis of EU/EEA clinical trial registries reveals a 13.5% decline in annual trial authorisations since 2022, driven ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine